基于MXene的平台在转移性膀癌中实现双重MiRNA向的治疗潜力
Negar Nayerain Jazi1, Sajad Alavimanesh2, Asma Vafadar3
1Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. ngar.nayerain@gmail.com.
Cancer cell international
|December 11, 2025
概括
MXene纳米颗粒通过提供双重microRNA疗法并使光热治疗成为可能,为转移性膀癌提供了一种新的治疗方法. 这一战略针对关键的瘤癌症,显示出克服治疗耐药性和阻止癌症扩散的前途.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 分子生物学分子生物学
背景情况:
- 转移性膀癌 (mBC) 具有挑战性,因为微RNA (miRNA) 失调促进瘤进展和治疗耐药性.
- miR-21促进癌症生长,而miR-200c抑制癌症生长,使得它们的联合向成为治疗策略.
- 2D纳米材料MXenes为药物输送和诊断提供了独特的特性.
研究的目的:
- 审查基于MXene的治疗神经系统在治疗转移性膀癌方面的潜力.
- 探索使用MXenes调节miR-21和miR-200c的联合治疗策略.
- 讨论纳米技术与分子瘤学的整合,用于精确的癌症治疗.
主要方法:
- 流行病学,分子瘤学和纳米技术文献的审查.
- 对MXene用于RNA传递和生物传感的物理化学性质的分析.
- 评估用于增强MXene生物相容性和性能的间隔方法.
- 对MXene介导的双miRNA输送和光热疗法的临床前数据的评估.
主要成果:
- MXenes可以有效地加载和传递抗miR-21和miR-200c模拟器.
- 在临床前的模型中,与光热疗法的同时交付证明了瘤的破坏.
- 电化学跟踪使得可以监测瘤内的miRNA活性.
- MXene系统实现了转移性过程的联合阻断.
结论:
- 基于MXene的双-miRNA治疗剂代表了转移性膀癌的有前途的精准医学方法.
- 通过生物降解涂料等创新解决降解和毒性等挑战至关重要.
- 进一步的开发有可能在mBC中进行变革性治疗.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.6K
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.8K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:22MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K